Table 3. Means and S.D. of the step length, crossing velocity and foot clearance of the more affected leg for both groups when stepping over obstacles.
PNF Group (n = 13) | Control Group (n = 14) | Time | Group | Group*pre/post | |||||
---|---|---|---|---|---|---|---|---|---|
p | η2p | p | η2p | p | η2p | ||||
Step length (m) | Week 0 | 0.62±0.02 | 0.62±0.03 | 0.436 | 0.025 | 0.940 | 0.000 | 0.709 | 0.065 |
Week 9 | 0.63±0.02 | 0.63±0.04 | |||||||
Crossing velocity (m/s) | Week 0 | 0.30±0.04* | 0.31±0.03 | –– | –– | –– | –– | 0.043 | 0.154 |
Week 9 | 0.33±0.03*# | 0.31±0.03# | |||||||
Foot clearance (m) | Week 0 | 0.18±0.02* | 0.17±0.03 | –– | –– | –– | –– | 0.004 | 0.284 |
Week 9 | 0.17±0.02* | 0.17±0.02 |
* Denotes significant difference in the PNF group between weeks 0 and 9.
a Denotes significant difference compared with the control group at week 9.